Most sensitive [Design Issues]

posted by The Outlaw Torn – Europe, 2011-11-02 13:49 (5352 d 19:42 ago) – Posting: # 7584
Views: 4,543

Dear all,

The guidelines say that single dose studies are the most sensitive at distinguishing formulation effects (section 4.1.1). However, we keep getting statements like this from authorities: A multiple dose study at the highest dose strength is considered to be most sensitive model for detecting differences.

Can someone explain why that would be so? And are there papers that discuss this?

Thanks.

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
265 visitors (0 registered, 265 guests [including 19 identified bots]).
Forum time: 10:31 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5